Sulfur Dioxide Protects Against Collagen Accumulation in Pulmonary Artery in Association With Downregulation of the Transforming Growth Factor β1/Smad Pathway in Pulmonary Hypertensive Rats
Open Access
- 3 October 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 5 (10)
Abstract
Background: We aimed to explore the role of endogenous sulfur dioxide ( SO 2 ) in pulmonary vascular collagen remodeling induced by monocrotaline and its mechanisms. Methods and Results: A rat model of monocrotaline‐induced pulmonary vascular collagen remodeling was developed and administered with l ‐aspartate‐β‐hydroxamate or SO 2 donor. The morphology of small pulmonary arteries and collagen metabolism were examined. Cultured pulmonary arterial fibroblasts stimulated by transforming growth factor β1 ( TGF ‐β1) were used to explore the mechanism. The results showed that in monocrotaline‐treated rats, mean pulmonary artery pressure increased markedly, small pulmonary arterial remodeling developed, and collagen deposition in lung tissue and pulmonary arteries increased significantly in association with elevated SO 2 content, aspartate aminotransferase (AAT) activity, and expression of AAT1 compared with control rats. Interestingly, l ‐aspartate‐β‐hydroxamate, an inhibitor of SO 2 generation, further aggravated pulmonary vascular collagen remodeling in monocrotaline‐treated rats, and inhibition of SO 2 in pulmonary artery smooth muscle cells activated collagen accumulation in pulmonary arterial fibroblasts. SO 2 donor, however, alleviated pulmonary vascular collagen remodeling with inhibited collagen synthesis, augmented collagen degradation, and decreased TGF ‐β1 expression of pulmonary arteries. Mechanistically, overexpression of AAT1, a key enzyme of SO 2 production, prevented the activation of the TGF ‐β/type I TGF ‐β receptor/Smad2/3 signaling pathway and abnormal collagen synthesis in pulmonary arterial fibroblasts. In contrast, knockdown of AAT1 exacerbated Smad2/3 phosphorylation and deposition of collagen types I and III in TGF ‐β1–treated pulmonary arterial fibroblasts. Conclusions: Endogenous SO 2 plays a protective role in pulmonary artery collagen accumulation induced by monocrotaline via inhibition of the TGF ‐β/type I TGF ‐β receptor/Smad2/3 pathway.Keywords
This publication has 57 references indexed in Scilit:
- TGF-Beta Induced Erk Phosphorylation of Smad Linker Region Regulates Smad SignalingPLOS ONE, 2012
- Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: involvement of hepatocyte STAT3 in TIMP-1 productionCell & Bioscience, 2011
- Role of extracellular superoxide in neutrophil activation: interactions between xanthine oxidase and TLR4 induce proinflammatory cytokine productionAmerican Journal of Physiology-Cell Physiology, 2008
- Exposure to hydrogen peroxide diminishes NF-κB activation, IκB-α degradation, and proteasome activity in neutrophilsAmerican Journal of Physiology-Cell Physiology, 2007
- The transforming growth factor-β/Smad2,3 signalling axis is impaired in experimental pulmonary hypertensionEuropean Respiratory Journal, 2007
- Pathology of Pulmonary HypertensionClinics in Chest Medicine, 2007
- Monocrotaline-induced pulmonary hypertension correlates with upregulation of connective tissue growth factor expression in the lungExperimental & Molecular Medicine, 2005
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- TGF-β 1 DNA Polymorphisms, Protein Levels, and Blood PressureHypertension, 1999
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976